Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Home Administration Of Nivestim(tm) In The Primary Prophylaxis Of Chemotherapy- Induced Febrile Neutropenia Non-interventional, Observational, Prospective Study Short Name: Home Short Name: Home

NCT02956967 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT02956967
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02956967 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Home Administration Of Nivestim(tm) In The Primary Prophylaxis Of Chemotherapy- Induced Febrile Neutropenia Non-interventional, Observational, Prospective Study Short Name: Home Short Name: Home
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
September 23, 2015
Completion date
December 12, 2016
Enrollment
171 (actual)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

non-interventional study